329 related articles for article (PubMed ID: 38240572)
21. Sporadic compared to recurrent urinary tract infections: Considerations for urogynecologic patients.
Bradley MS; Cabrera C; Clark SG; Sassani J; Venuti K; Ackenbom MF
Neurourol Urodyn; 2020 Nov; 39(8):2186-2191. PubMed ID: 32803912
[TBL] [Abstract][Full Text] [Related]
22. CpxA Phosphatase Inhibitor Activates CpxRA and Is a Potential Treatment for Uropathogenic Escherichia coli in a Murine Model of Infection.
Fortney KR; Smith SN; van Rensburg JJ; Brothwell JA; Gardner JJ; Katz BP; Ahsan N; Duerfeldt AS; Mobley HLT; Spinola SM
Microbiol Spectr; 2022 Apr; 10(2):e0243021. PubMed ID: 35297652
[TBL] [Abstract][Full Text] [Related]
23. Selection of Effective Antibiotics for Uropathogenic
González MJ; Zunino P; Scavone P; Robino L
Front Cell Infect Microbiol; 2020; 10():542755. PubMed ID: 33194792
[TBL] [Abstract][Full Text] [Related]
24. Rapid Bladder Interleukin-10 Synthesis in Response to Uropathogenic Escherichia coli Is Part of a Defense Strategy Triggered by the Major Bacterial Flagellar Filament FliC and Contingent on TLR5.
Acharya D; Sullivan MJ; Duell BL; Goh KGK; Katupitiya L; Gosling D; Chamoun MN; Kakkanat A; Chattopadhyay D; Crowley M; Crossman DK; Schembri MA; Ulett GC
mSphere; 2019 Nov; 4(6):. PubMed ID: 31776239
[TBL] [Abstract][Full Text] [Related]
25. Comparative Genomics of Antibiotic-Resistant Uropathogens Implicates Three Routes for Recurrence of Urinary Tract Infections.
Thänert R; Reske KA; Hink T; Wallace MA; Wang B; Schwartz DJ; Seiler S; Cass C; Burnham CA; Dubberke ER; Kwon JH; Dantas G
mBio; 2019 Aug; 10(4):. PubMed ID: 31455657
[TBL] [Abstract][Full Text] [Related]
26. Emerging Non-Antibiotic Options Targeting Uropathogenic Mechanisms for Recurrent Uncomplicated Urinary Tract Infection.
Chen YC; Lee WC; Chuang YC
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108218
[TBL] [Abstract][Full Text] [Related]
27. Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection.
Forsyth VS; Himpsl SD; Smith SN; Sarkissian CA; Mike LA; Stocki JA; Sintsova A; Alteri CJ; Mobley HLT
mBio; 2020 Apr; 11(2):. PubMed ID: 32345645
[TBL] [Abstract][Full Text] [Related]
28. A non-canonical autophagy-dependent role of the ATG16L1
Wang C; Bauckman KA; Ross ASB; Symington JW; Ligon MM; Scholtes G; Kumar A; Chang HW; Twentyman J; Fashemi BE; Xavier RJ; Mysorekar IU
Autophagy; 2019 Mar; 15(3):527-542. PubMed ID: 30335568
[TBL] [Abstract][Full Text] [Related]
29. Dynamic persistence of UPEC intracellular bacterial communities in a human bladder-chip model of urinary tract infection.
Sharma K; Dhar N; Thacker VV; Simonet TM; Signorino-Gelo F; Knott GW; McKinney JD
Elife; 2021 Jul; 10():. PubMed ID: 34219648
[TBL] [Abstract][Full Text] [Related]
30. Peptidoglycan Sensing Prevents Quiescence and Promotes Quorum-Independent Colony Growth of Uropathogenic Escherichia coli.
DiBiasio EC; Ranson HJ; Johnson JR; Rowley DC; Cohen PS; Camberg JL
J Bacteriol; 2020 Sep; 202(20):. PubMed ID: 32778561
[TBL] [Abstract][Full Text] [Related]
31. RNase 7 Inhibits Uropathogenic
Ho CH; Liao PW; Fan CK; Liu SP; Cheng PC
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563546
[TBL] [Abstract][Full Text] [Related]
32. Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation.
van Nieuwkoop C; den Exter PL; Elzevier HW; den Hartigh J; van Dissel JT
Int J Antimicrob Agents; 2010 Dec; 36(6):485-90. PubMed ID: 20580533
[TBL] [Abstract][Full Text] [Related]
33. Antibiotic Resistance Among Uropathogenic
Kot B
Pol J Microbiol; 2019 Dec; 68(4):403-415. PubMed ID: 31880885
[TBL] [Abstract][Full Text] [Related]
34. Luteolin decreases the attachment, invasion and cytotoxicity of UPEC in bladder epithelial cells and inhibits UPEC biofilm formation.
Shen XF; Ren LB; Teng Y; Zheng S; Yang XL; Guo XJ; Wang XY; Sha KH; Li N; Xu GY; Tian HW; Wang XY; Liu XK; Li J; Huang N
Food Chem Toxicol; 2014 Oct; 72():204-11. PubMed ID: 25051393
[TBL] [Abstract][Full Text] [Related]
35. Intravesical gentamicin instillation for the treatment and prevention of urinary tract infections in complex paediatric urology patients: evidence for safety and efficacy.
Marei MM; Jackson R; Keene DJB
J Pediatr Urol; 2021 Feb; 17(1):65.e1-65.e11. PubMed ID: 33309610
[TBL] [Abstract][Full Text] [Related]
36. Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice.
O'Brien VP; Joens MS; Lewis AL; Gilbert NM
J Vis Exp; 2020 Dec; (166):. PubMed ID: 33346201
[TBL] [Abstract][Full Text] [Related]
37. Uropathogenic
Alfuraiji N; Al-Hamami A; Ibrahim M; Rajab HK; Hussain BW
J Med Life; 2022 May; 15(5):650-654. PubMed ID: 35815089
[TBL] [Abstract][Full Text] [Related]
38. Fosfomycin tromethamine activity on biofilm and intracellular bacterial communities produced by uropathogenic Escherichia coli isolated from patients with urinary tract infection.
González MJ; Da Cunda P; Notejane M; Zunino P; Scavone P; Robino L
Pathog Dis; 2019 Apr; 77(3):. PubMed ID: 31062019
[TBL] [Abstract][Full Text] [Related]
39. Crude polysaccharides from the seeds of Vaccaria segetalis prevent the urinary tract infection through the stimulation of kidney innate immunity.
Mao X; Guo H; Yao R; Bao L; Sun J; Bao Y; Guo B; Gao Y; Shi Y; Zhang H; Cui X
J Ethnopharmacol; 2020 Oct; 260():112578. PubMed ID: 31962152
[TBL] [Abstract][Full Text] [Related]
40. Augmentation of Urinary Lactoferrin Enhances Host Innate Immune Clearance of Uropathogenic Escherichia coli.
Patras KA; Ha AD; Rooholfada E; Olson J; Ramachandra Rao SP; Lin AE; Nizet V
J Innate Immun; 2019; 11(6):481-495. PubMed ID: 31055580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
